ANPEP and inflammatory bowel disease: Gut dysfunction in patients with active IBD may be connected with changes in many factors, for instance increased prostaglandin levels as a result of COX-2 overexpression in neural cells of the myenteric plexus or decreased opioid peptides level rapidly degraded by endogenous enzymes (NEP, APN, DPPIII, and ACE).